Jonathan Poole

2017 - Genocea Biosciences

In 2017, Jonathan Poole earned a total compensation of $1.2M as Former Chief Financial Officer at Genocea Biosciences, a 63% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$95,288
Option Awards$417,542
Salary$390,625
Stock Awards$300,006
Other$6,295
Total$1,209,756

Poole received $417.5K in option awards, accounting for 35% of the total pay in 2017.

Poole also received $95.3K in non-equity incentive plan, $390.6K in salary, $300K in stock awards and $6.3K in other compensation.

Rankings

In 2017, Jonathan Poole's compensation ranked 8,066th out of 14,666 executives tracked by ExecPay. In other words, Poole earned more than 45.0% of executives.

ClassificationRankingPercentile
All
8,066
out of 14,666
45th
Division
Manufacturing
3,038
out of 5,772
47th
Major group
Chemicals And Allied Products
1,000
out of 2,075
52nd
Industry group
Drugs
783
out of 1,731
55th
Industry
Biological Products, Except Diagnostic Substances
142
out of 313
55th
Source: SEC filing on April 24, 2018.

Poole's colleagues

We found five more compensation records of executives who worked with Jonathan Poole at Genocea Biosciences in 2017.

2017

William Clark

Genocea Biosciences

Chief Executive Officer

2017

Seth Hetherington

Genocea Biosciences

Chief Medical Officer

2017

Jessica Fletchner

Genocea Biosciences

Chief Scientific Officer

2017

Eric Hoffman

Genocea Biosciences

Former Chief Business Officer

2017

Pamela Carroll

Genocea Biosciences

Senior Vice President, Immuno, Oncology

News

You may also like